Abstract
Heart plays a vital role in the human life survival. Now a days the global burden of heart problems is very high. There is very high mortality rate. So in this review we aimed to explore the cardioprotective drug dexrazoxane. Now, dexrazoxane has received approval for two different uses: avoiding tissue damage after anthracycline extravasation and preventing cardiotoxicity during anthracycline-based chemotherapy. Regardless of existing cardiac risk factors, the medication seems to provide cardiac protection. Dexrazoxane is a bisdioxopiperazine with iron-chelating, chemoprotective, cardioprotective, and antineoplastic properties, according to the prior study. So this study suggests that the dexrazoxane will play very important role in the treatment of cardiac problems.Keywords- Dexrazoxane, Anthracycline, Cardiotoxicity, Cardiovascular Disease, Chemotherapy, Doxorubicin
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
